Literature DB >> 26508510

Host Genetic Susceptibility to Enteric Viruses: A Systematic Review and Metaanalysis.

Anita Kambhampati1,2, Daniel C Payne1, Veronica Costantini1, Benjamin A Lopman1.   

Abstract

BACKGROUND: Norovirus and rotavirus are prominent enteric viruses responsible for severe acute gastroenteritis disease burden around the world. Both viruses recognize and bind to histo-blood group antigens, which are expressed by the fucosyltransferase 2 (FUT2) gene. Individuals with a functional FUT2 gene are termed "secretors." FUT2 polymorphisms may influence viral binding patterns and, therefore, may influence host susceptibility to infection by these viruses.
METHODS: We performed a systematic review of the published literature on this topic. Data were abstracted and compiled for descriptive analyses and metaanalyses. We estimated pooled odds ratios (ORs) for infection using random-effects models.
RESULTS: We found that secretors were 9.9 times (95% confidence interval [CI], 3.9-24.8) as likely to be infected with genogroup II.4 noroviruses and 2.2 times as likely to be infected with genogroup II non-4 noroviruses (95% CI, 1.2-4.2) compared with nonsecretors. Secretors were also 26.6 times more susceptible to infections from P[8]-type rotaviruses compared with nonsecretors (95% CI, 8.3-85.0).
CONCLUSIONS: Our analyses indicate that host genetic susceptibility to norovirus and rotavirus infection may be strain specific. As strain distribution and the proportion of genetic phenotypes vary in different countries, future studies should focus on differences in susceptibility among various ethnicities. Knowledge of innate susceptibility to rotavirus and norovirus can lead to improved understanding of both vaccine performance and individual risk of disease. Published by Oxford University Press for the Infectious Diseases Society of America 2015. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  FUT2; histo-blood group antigen; norovirus; rotavirus

Mesh:

Substances:

Year:  2015        PMID: 26508510      PMCID: PMC4679673          DOI: 10.1093/cid/civ873

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  28 in total

1.  Norovirus illness is a global problem: emergence and spread of norovirus GII.4 variants, 2001-2007.

Authors:  J Joukje Siebenga; Harry Vennema; Du-Ping Zheng; Jan Vinjé; Bonita E Lee; Xiao-Li Pang; Eric C M Ho; Wilina Lim; Avinash Choudekar; Shobha Broor; Tamar Halperin; Nassar B G Rasool; Joanne Hewitt; Gail E Greening; Miao Jin; Zhao-Jun Duan; Yalda Lucero; Miguel O'Ryan; Marina Hoehne; Eckart Schreier; Rodney M Ratcliff; Peter A White; Nobuhiro Iritani; Gábor Reuter; Marion Koopmans
Journal:  J Infect Dis       Date:  2009-09-01       Impact factor: 5.226

Review 2.  Mechanisms of GII.4 norovirus evolution.

Authors:  Rowena A Bull; Peter A White
Journal:  Trends Microbiol       Date:  2011-02-09       Impact factor: 17.079

3.  Spike protein VP8* of human rotavirus recognizes histo-blood group antigens in a type-specific manner.

Authors:  Pengwei Huang; Ming Xia; Ming Tan; Weiming Zhong; Chao Wei; Leyi Wang; Ardythe Morrow; Xi Jiang
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

Review 4.  2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis.

Authors:  Jacqueline E Tate; Anthony H Burton; Cynthia Boschi-Pinto; A Duncan Steele; Jazmin Duque; Umesh D Parashar
Journal:  Lancet Infect Dis       Date:  2011-10-24       Impact factor: 25.071

5.  Rotavirus VP8*: phylogeny, host range, and interaction with histo-blood group antigens.

Authors:  Yang Liu; Pengwei Huang; Ming Tan; Yiliu Liu; Jacek Biesiada; Jarek Meller; Alejandro A Castello; Baoming Jiang; Xi Jiang
Journal:  J Virol       Date:  2012-07-03       Impact factor: 5.103

6.  A natural history of FUT2 polymorphism in humans.

Authors:  Anna Ferrer-Admetlla; Martin Sikora; Hafid Laayouni; Anna Esteve; Francis Roubinet; Antoine Blancher; Francesc Calafell; Jaume Bertranpetit; Ferran Casals
Journal:  Mol Biol Evol       Date:  2009-06-01       Impact factor: 16.240

7.  Norovirus and medically attended gastroenteritis in U.S. children.

Authors:  Daniel C Payne; Jan Vinjé; Peter G Szilagyi; Kathryn M Edwards; Mary Allen Staat; Geoffrey A Weinberg; Caroline B Hall; James Chappell; David I Bernstein; Aaron T Curns; Mary Wikswo; S Hannah Shirley; Aron J Hall; Benjamin Lopman; Umesh D Parashar
Journal:  N Engl J Med       Date:  2013-03-21       Impact factor: 91.245

8.  Novel surveillance network for norovirus gastroenteritis outbreaks, United States.

Authors:  Everardo Vega; Leslie Barclay; Nicole Gregoricus; Kara Williams; David Lee; Jan Vinjé
Journal:  Emerg Infect Dis       Date:  2011-08       Impact factor: 6.883

9.  Effects and clinical significance of GII.4 Sydney norovirus, United States, 2012-2013.

Authors:  Eyal Leshem; Mary Wikswo; Leslie Barclay; Eric Brandt; William Storm; Ellen Salehi; Traci DeSalvo; Tim Davis; Amy Saupe; Ginette Dobbins; Hillary A Booth; Christianne Biggs; Katie Garman; Amy M Woron; Umesh D Parashar; Jan Vinjé; Aron J Hall
Journal:  Emerg Infect Dis       Date:  2013-08       Impact factor: 6.883

10.  Major reduction of rotavirus, but not norovirus, gastroenteritis in children seen in hospital after the introduction of RotaTeq vaccine into the National Immunization Programme in Finland.

Authors:  Maria Hemming; Sirpa Räsänen; Leena Huhti; Minna Paloniemi; Marjo Salminen; Timo Vesikari
Journal:  Eur J Pediatr       Date:  2013-01-30       Impact factor: 3.183

View more
  49 in total

Review 1.  Overview of the Development, Impacts, and Challenges of Live-Attenuated Oral Rotavirus Vaccines.

Authors:  Olufemi Samuel Folorunso; Olihile M Sebolai
Journal:  Vaccines (Basel)       Date:  2020-06-27

Review 2.  Norovirus Illnesses in Children and Adolescents.

Authors:  Minesh P Shah; Aron J Hall
Journal:  Infect Dis Clin North Am       Date:  2018-03       Impact factor: 5.982

3.  Understanding the Importance of Contact Heterogeneity and Variable Infectiousness in the Dynamics of a Large Norovirus Outbreak.

Authors:  Jon Zelner; Carly Adams; Joshua Havumaki; Ben Lopman
Journal:  Clin Infect Dis       Date:  2020-01-16       Impact factor: 9.079

Review 4.  Towards a Universal Molecular Microbiological Test.

Authors:  Richard J N Allcock; Amy V Jennison; David Warrilow
Journal:  J Clin Microbiol       Date:  2017-08-23       Impact factor: 5.948

5.  Wading Into the Morass: Natural Immunity to Enteropathogens.

Authors:  Benjamin A Lopman; Julia M Baker
Journal:  J Infect Dis       Date:  2020-11-09       Impact factor: 5.226

Review 6.  Norovirus Regulation by Host and Microbe.

Authors:  Megan T Baldridge; Holly Turula; Christiane E Wobus
Journal:  Trends Mol Med       Date:  2016-11-22       Impact factor: 11.951

7.  Transcriptomic Analysis of the Host Response and Innate Resilience to Enterotoxigenic Escherichia coli Infection in Humans.

Authors:  William E Yang; Sunil Suchindran; Bradly P Nicholson; Micah T McClain; Thomas Burke; Geoffrey S Ginsburg; Clayton D Harro; Subhra Chakraborty; David A Sack; Christopher W Woods; Ephraim L Tsalik
Journal:  J Infect Dis       Date:  2016-01-18       Impact factor: 5.226

8.  Evaluating strategies to improve rotavirus vaccine impact during the second year of life in Malawi.

Authors:  Virginia E Pitzer; Aisleen Bennett; Naor Bar-Zeev; Khuzwayo C Jere; Benjamin A Lopman; Joseph A Lewnard; Umesh D Parashar; Nigel A Cunliffe
Journal:  Sci Transl Med       Date:  2019-08-14       Impact factor: 17.956

9.  Birth Cohort Studies Assessing Norovirus Infection and Immunity in Young Children: A Review.

Authors:  Jennifer L Cannon; Benjamin A Lopman; Daniel C Payne; Jan Vinjé
Journal:  Clin Infect Dis       Date:  2019-07-02       Impact factor: 9.079

Review 10.  Epithelial glycosylation in gut homeostasis and inflammation.

Authors:  Yoshiyuki Goto; Satoshi Uematsu; Hiroshi Kiyono
Journal:  Nat Immunol       Date:  2016-10-19       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.